ROC-话题@MedSci

#ROC#

194篇内容 | 3530人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1976891, encodeId=c0d619e6891ad, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=J Neurochem：区分缺血性卒中和出血性卒中的生物标记物：RBP4 和GFAP, objectType=article, longId=58428, objectId=7e9458428ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e9458428ff, replyNumber=0, likeNumber=80, createdTime=2016-09-06, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e9458428ff, moduleTitle=J Neurochem：区分缺血性卒中和出血性卒中的生物标记物：RBP4 和GFAP, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e9458428ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976886, encodeId=b78e19e68862e, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=新型降脂药Alirocumab获FDA批准和欧洲CHMP批准建议, objectType=article, longId=54169, objectId=cbdb541696e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbdb541696e, replyNumber=0, likeNumber=84, createdTime=2015-12-28, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbdb541696e, moduleTitle=新型降脂药Alirocumab获FDA批准和欧洲CHMP批准建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbdb541696e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976884, encodeId=ecfc19e6884e1, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=诊断性研究中的ROC曲线分析, objectType=article, longId=50214, objectId=de675021419, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de675021419, replyNumber=0, likeNumber=77, createdTime=2015-06-18, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de675021419, moduleTitle=诊断性研究中的ROC曲线分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de675021419)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976895, encodeId=324619e689524, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Mayo Clin Proc：美国老年人带状疱疹发生后，心肌梗死和卒中发生风险增加, objectType=article, longId=62519, objectId=2fba6251988, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fba6251988, replyNumber=0, likeNumber=73, createdTime=2016-08-04, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fba6251988, moduleTitle=Mayo Clin Proc：美国老年人带状疱疹发生后，心肌梗死和卒中发生风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fba6251988)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976888, encodeId=c84819e688886, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Proc Natl Acad Sci：吗啉代低聚物（MO）能改变疟疾的疟原虫的RNA转录，克服耐药, objectType=article, longId=56005, objectId=67b656005c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67b656005c2, replyNumber=0, likeNumber=85, createdTime=2015-11-09, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67b656005c2, moduleTitle=Proc Natl Acad Sci：吗啉代低聚物（MO）能改变疟疾的疟原虫的RNA转录，克服耐药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67b656005c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976885, encodeId=3e4e19e688596, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Mayo Clin Proc：关于降低抗癌药物价格的一份声明——**肿瘤专家支持患者请求, objectType=article, longId=53808, objectId=34b3538088b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34b3538088b, replyNumber=0, likeNumber=63, createdTime=2015-08-05, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34b3538088b, moduleTitle=Mayo Clin Proc：关于降低抗癌药物价格的一份声明——**肿瘤专家支持患者请求, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34b3538088b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976880, encodeId=b9e919e6880a6, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=NEJM：新药Alirocumab能够安全降脂, objectType=article, longId=48257, objectId=1a9e4825ee4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a9e4825ee4, replyNumber=0, likeNumber=122, createdTime=2016-01-24, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a9e4825ee4, moduleTitle=NEJM：新药Alirocumab能够安全降脂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a9e4825ee4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976883, encodeId=4ef219e68839e, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=NEJM：Rociletinib药物在EGFR突变的非小细胞肺癌效应评估, objectType=article, longId=50094, objectId=e5e1500947f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5e1500947f, replyNumber=0, likeNumber=70, createdTime=2015-08-02, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5e1500947f, moduleTitle=NEJM：Rociletinib药物在EGFR突变的非小细胞肺癌效应评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5e1500947f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976882, encodeId=9ab819e688202, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=NEJM：PCSK9抑制剂Alirocumab联合大剂量他汀可显著降低LDL-C水平, objectType=article, longId=49564, objectId=fcff495646e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcff495646e, replyNumber=0, likeNumber=97, createdTime=2015-10-28, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcff495646e, moduleTitle=NEJM：PCSK9抑制剂Alirocumab联合大剂量他汀可显著降低LDL-C水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcff495646e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976889, encodeId=216d19e6889f2, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=招募患者：未接受过治疗的儿童血友病A患者中应用turoctocog alfa预防和治疗出血的安全性和有效性临床试验, objectType=article, longId=56020, objectId=e4b556020a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4b556020a4, replyNumber=0, likeNumber=70, createdTime=2016-05-11, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4b556020a4, moduleTitle=招募患者：未接受过治疗的儿童血友病A患者中应用turoctocog alfa预防和治疗出血的安全性和有效性临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4b556020a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976874, encodeId=86bd19e6874cd, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Rock Health报告：从预测性分析走向个性化医疗, objectType=article, longId=42032, objectId=92c242032af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92c242032af, replyNumber=0, likeNumber=75, createdTime=2015-01-17, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92c242032af, moduleTitle=Rock Health报告：从预测性分析走向个性化医疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92c242032af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976876, encodeId=9aa319e687648, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=诊断性研究中的ROC曲线分析（1）, objectType=article, longId=43290, objectId=7cea43290e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cea43290e3, replyNumber=0, likeNumber=46, createdTime=2015-06-22, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cea43290e3, moduleTitle=诊断性研究中的ROC曲线分析（1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cea43290e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976877, encodeId=b32b19e68776e, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=诊断性研究中的ROC曲线分析（4）, objectType=article, longId=43319, objectId=5a454331958, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a454331958, replyNumber=0, likeNumber=48, createdTime=2015-05-12, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a454331958, moduleTitle=诊断性研究中的ROC曲线分析（4）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a454331958)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976878, encodeId=330d19e6878fc, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=诊断性研究中的ROC曲线分析（3）, objectType=article, longId=43320, objectId=b360433207f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b360433207f, replyNumber=0, likeNumber=50, createdTime=2015-07-12, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b360433207f, moduleTitle=诊断性研究中的ROC曲线分析（3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b360433207f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976881, encodeId=97d819e68817c, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Neurocrit Care：新型自发性脑出血动物模型可用地研究造影响剂外溢, objectType=article, longId=48712, objectId=e85648e123b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e85648e123b, replyNumber=0, likeNumber=100, createdTime=2015-05-15, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e85648e123b, moduleTitle=Neurocrit Care：新型自发性脑出血动物模型可用地研究造影响剂外溢, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e85648e123b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976879, encodeId=9d3f19e687910, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=诊断性研究中的ROC曲线分析（2）, objectType=article, longId=43321, objectId=205743321a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=205743321a8, replyNumber=0, likeNumber=39, createdTime=2015-11-08, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=205743321a8, moduleTitle=诊断性研究中的ROC曲线分析（2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=205743321a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976872, encodeId=629d19e68722f, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=赛诺菲PCSK9抑制剂alirocumab 9个III期均达主要疗效终点, objectType=article, longId=38618, objectId=b1903861805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1903861805, replyNumber=0, likeNumber=62, createdTime=2014-09-25, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1903861805, moduleTitle=赛诺菲PCSK9抑制剂alirocumab 9个III期均达主要疗效终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1903861805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976873, encodeId=480b19e687357, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Mayo Clin Proc：拒绝过度运动科学研究出每日更佳运动量, objectType=article, longId=40922, objectId=87db409226e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87db409226e, replyNumber=0, likeNumber=71, createdTime=2015-04-20, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87db409226e, moduleTitle=Mayo Clin Proc：拒绝过度运动科学研究出每日更佳运动量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87db409226e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976871, encodeId=685119e6871a9, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Mayo Clinic Proceedings：研究人员用麻疹病毒“治愈”骨髓瘤, objectType=article, longId=34887, objectId=cd223488eb6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd223488eb6, replyNumber=0, likeNumber=56, createdTime=2014-09-23, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd223488eb6, moduleTitle=Mayo Clinic Proceedings：研究人员用麻疹病毒“治愈”骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd223488eb6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976875, encodeId=eaa219e6875a2, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=赛诺菲、Regeneron开发PCSK9新药alirocumab临床试验击败Zetia, objectType=article, longId=42968, objectId=df2042968c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2042968c5, replyNumber=0, likeNumber=60, createdTime=2015-01-26, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2042968c5, moduleTitle=赛诺菲、Regeneron开发PCSK9新药alirocumab临床试验击败Zetia, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df2042968c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ROC

2020-05-29

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

J Neurochem：区分缺血性卒中和出血性卒中的生物标记物：RBP4 和GFAP

2016-09-06

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

新型降脂药Alirocumab获FDA批准和欧洲CHMP批准建议

2015-12-28

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

诊断性研究中的ROC曲线分析

2015-06-18

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Mayo Clin Proc：美国老年人带状疱疹发生后，心肌梗死和卒中发生风险增加

2016-08-04

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Proc Natl Acad Sci：吗啉代低聚物（MO）能改变疟疾的疟原虫的RNA转录，克服耐药

2015-11-09

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Mayo Clin Proc：关于降低抗癌药物价格的一份声明——**肿瘤专家支持患者请求

2015-08-05

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

NEJM：新药Alirocumab能够安全降脂

2016-01-24

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

NEJM：Rociletinib药物在EGFR突变的非小细胞肺癌效应评估

2015-08-02

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

NEJM：PCSK9抑制剂Alirocumab联合大剂量他汀可显著降低LDL-C水平

2015-10-28

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

招募患者：未接受过治疗的儿童血友病A患者中应用turoctocog alfa预防和治疗出血的安全性和有效性临床试验

2016-05-11

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Rock Health报告：从预测性分析走向个性化医疗

2015-01-17

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

诊断性研究中的ROC曲线分析（1）

2015-06-22

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

诊断性研究中的ROC曲线分析（4）

2015-05-12

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

诊断性研究中的ROC曲线分析（3）

2015-07-12

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Neurocrit Care：新型自发性脑出血动物模型可用地研究造影响剂外溢

2015-05-15

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

诊断性研究中的ROC曲线分析（2）

2015-11-08

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

赛诺菲PCSK9抑制剂alirocumab 9个III期均达主要疗效终点

2014-09-25

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Mayo Clin Proc：拒绝过度运动科学研究出每日更佳运动量

2015-04-20

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Mayo Clinic Proceedings：研究人员用麻疹病毒“治愈”骨髓瘤

2014-09-23

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

赛诺菲、Regeneron开发PCSK9新药alirocumab临床试验击败Zetia

2015-01-26

科室
- - 订阅+
  - 更多科室
工具
服务